Cancer Drug Costs Rs 2,700, Sells for Rs 27,000: SC Questions 10x Markup at Hospitals
The bench said a cancer drug sold at Rs 27,000 after costing retailers about Rs 2,700, and asked whether a uniform 16% margin should apply.
8 Articles
8 Articles
Who pays? Taxpayer: SC questions inflated medicine prices at private hospitals
The Supreme Court questioned steep medicine mark-ups at corporate hospitals and their insistence on in-house pharmacies. It said the burden of inflated pricing falls on patients and taxpayers, especially under government schemes.
The Economic Times
Times of IndiaCancer drug costs Rs 2,700, sells for Rs 27,000: SC questions 10x markup at hospitals
The Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The court also sought scrutiny of hospitals that force patients to buy drugs from in-house pharmacies, saying such practices burden patients and taxpayers.
New Delhi, Sept. 29 (IANS) The Supreme Court has once again posed tough questions to the central government regarding the huge difference between the MRP and the price to retailer (PTR) of cancer drugs. The court asked why there is such a difference in the system for determining the price of medicines and whether essential items can be kept out of price control. Justice Sandeep Mehta, during the hearing, noted that the price to retailer of a can…
Coverage Details
Bias Distribution
- 66% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
